Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure

NCT00245310 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00245310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Completed
Start date
October 31, 2005
Completion date
October 31, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute liver failure, liver cirrhosis